Magnus Lindskog

Baseline laboratory values and metastatic burden predict survival in addition to IMDC risk in real-world renal cell carcinoma patients treated with ipilimumab-nivolumab

Kheir, Alaa; Johannsdottir, Berglind; Gronn-Weiss, Alexandra; Liu, Lisa L. et al.

Ingår i Acta Oncologica, s. 1355-1364, 2025

• DOI för Baseline laboratory values and metastatic burden predict survival in addition to IMDC risk in real-world renal cell carcinoma patients treated with ipilimumab-nivolumab
• Ladda ner fulltext (pdf) av Baseline laboratory values and metastatic burden predict survival in addition to IMDC risk in real-world renal cell carcinoma patients treated with ipilimumab-nivolumab

Bronchoscopic intervention reduces dyspnea in severely symptomatic patients with central malignant airway obstruction

Svensson, Malin; Palm, Andreas; Westo, Nilla; Lindskog, Magnus

Ingår i Journal of Pain and Symptom Management, s. 38-45, 2025

• DOI för Bronchoscopic intervention reduces dyspnea in severely symptomatic patients with central malignant airway obstruction
• Ladda ner fulltext (pdf) av Bronchoscopic intervention reduces dyspnea in severely symptomatic patients with central malignant airway obstruction

Predictors of survival and recurrence patterns following definitive chemoradiotherapy in stage III non-small cell lung cancer: a retrospective cohort study

Broström, Erika; Isaksson, Johan; Xanthoulis, Panagiotis; Börjesson, Rebecka et al.

Ingår i Translational Lung Cancer Research, s. 1972-1985, 2025

• DOI för Predictors of survival and recurrence patterns following definitive chemoradiotherapy in stage III non-small cell lung cancer: a retrospective cohort study
• Ladda ner fulltext (pdf) av Predictors of survival and recurrence patterns following definitive chemoradiotherapy in stage III non-small cell lung cancer: a retrospective cohort study

Competing risk of death in patients with low, intermediate and high risk of recurrence after radical surgery for clear cell renal cell carcinoma

Braennbaeck, Anna; Mustonen, Ivan; Laajala, Teemu D.; Vainio, Paula et al.

Ingår i BJUI Compass, 2025

• DOI för Competing risk of death in patients with low, intermediate and high risk of recurrence after radical surgery for clear cell renal cell carcinoma

The value of whole-body MRI instead of only brain MRI in addition to 18 F-FDG PET/CT in the staging of advanced non-small-cell lung cancer

Holmstrand, Hanna; Lindskog, Magnus; Sundin, Anders; Hansen, Tomas

Ingår i Cancer Imaging, 2025

• DOI för The value of whole-body MRI instead of only brain MRI in addition to 18 F-FDG PET/CT in the staging of advanced non-small-cell lung cancer
• Ladda ner fulltext (pdf) av The value of whole-body MRI instead of only brain MRI in addition to 18 F-FDG PET/CT in the staging of advanced non-small-cell lung cancer

Baseline laboratory values and metastatic burden predict survival in addition to IMDC risk in real-world renal cell carcinoma patients treated with ipilimumab-nivolumab

Kheir, Alaa; Johannsdottir, Berglind; Gronn-Weiss, Alexandra; Liu, Lisa L. et al.

Ingår i Acta Oncologica, s. 1355-1364, 2025

• DOI för Baseline laboratory values and metastatic burden predict survival in addition to IMDC risk in real-world renal cell carcinoma patients treated with ipilimumab-nivolumab
• Ladda ner fulltext (pdf) av Baseline laboratory values and metastatic burden predict survival in addition to IMDC risk in real-world renal cell carcinoma patients treated with ipilimumab-nivolumab

Bronchoscopic intervention reduces dyspnea in severely symptomatic patients with central malignant airway obstruction

Svensson, Malin; Palm, Andreas; Westo, Nilla; Lindskog, Magnus

Ingår i Journal of Pain and Symptom Management, s. 38-45, 2025

• DOI för Bronchoscopic intervention reduces dyspnea in severely symptomatic patients with central malignant airway obstruction
• Ladda ner fulltext (pdf) av Bronchoscopic intervention reduces dyspnea in severely symptomatic patients with central malignant airway obstruction

Predictors of survival and recurrence patterns following definitive chemoradiotherapy in stage III non-small cell lung cancer: a retrospective cohort study

Broström, Erika; Isaksson, Johan; Xanthoulis, Panagiotis; Börjesson, Rebecka et al.

Ingår i Translational Lung Cancer Research, s. 1972-1985, 2025

• DOI för Predictors of survival and recurrence patterns following definitive chemoradiotherapy in stage III non-small cell lung cancer: a retrospective cohort study
• Ladda ner fulltext (pdf) av Predictors of survival and recurrence patterns following definitive chemoradiotherapy in stage III non-small cell lung cancer: a retrospective cohort study

Competing risk of death in patients with low, intermediate and high risk of recurrence after radical surgery for clear cell renal cell carcinoma

Braennbaeck, Anna; Mustonen, Ivan; Laajala, Teemu D.; Vainio, Paula et al.

Ingår i BJUI Compass, 2025

• DOI för Competing risk of death in patients with low, intermediate and high risk of recurrence after radical surgery for clear cell renal cell carcinoma

The value of whole-body MRI instead of only brain MRI in addition to 18 F-FDG PET/CT in the staging of advanced non-small-cell lung cancer

Holmstrand, Hanna; Lindskog, Magnus; Sundin, Anders; Hansen, Tomas

Ingår i Cancer Imaging, 2025

• DOI för The value of whole-body MRI instead of only brain MRI in addition to 18 F-FDG PET/CT in the staging of advanced non-small-cell lung cancer
• Ladda ner fulltext (pdf) av The value of whole-body MRI instead of only brain MRI in addition to 18 F-FDG PET/CT in the staging of advanced non-small-cell lung cancer

Fluid therapy is associated with lower care quality and higher symptom burden during last days of life of patients with cancer: - a population-based register study

Lindskog, Magnus; Mogensen, Hanna; Tavelin, Bjoern; Eknert, Johanna et al.

Ingår i BMC Palliative Care, 2024

• DOI för Fluid therapy is associated with lower care quality and higher symptom burden during last days of life of patients with cancer: - a population-based register study
• Ladda ner fulltext (pdf) av Fluid therapy is associated with lower care quality and higher symptom burden during last days of life of patients with cancer: - a population-based register study

Immuno-oncological effects of standard anticancer agents and commonly used concomitant drugs: an in vitro assessment

Selvin, Tove; Berglund, Malin; Lenhammar, Lena; Lindskog, Magnus et al.

Ingår i BMC Pharmacology & Toxicology, 2024

• DOI för Immuno-oncological effects of standard anticancer agents and commonly used concomitant drugs: an in vitro assessment
• Ladda ner fulltext (pdf) av Immuno-oncological effects of standard anticancer agents and commonly used concomitant drugs: an in vitro assessment

Effect of Disulfiram and Copper Plus Chemotherapy vs Chemotherapy Alone on Survival in Patients With Recurrent Glioblastoma: A Randomized Clinical Trial

Werlenius, Katja; Kinhult, Sara; Solheim, Tora Skeidsvoll; Magelssen, Henriette et al.

Ingår i JAMA Network Open, 2023

• DOI för Effect of Disulfiram and Copper Plus Chemotherapy vs Chemotherapy Alone on Survival in Patients With Recurrent Glioblastoma: A Randomized Clinical Trial
• Ladda ner fulltext (pdf) av Effect of Disulfiram and Copper Plus Chemotherapy vs Chemotherapy Alone on Survival in Patients With Recurrent Glioblastoma: A Randomized Clinical Trial

Matched Analyses of Brain Metastases versus Primary Non-Small Cell Lung Cancer Reveal a Unique microRNA Signature

Tsakonas, Georgios; Koulouris, Andreas; Kazmierczak, Dominika; Botling, Johan et al.

Ingår i International Journal of Molecular Sciences, 2023

• DOI för Matched Analyses of Brain Metastases versus Primary Non-Small Cell Lung Cancer Reveal a Unique microRNA Signature
• Ladda ner fulltext (pdf) av Matched Analyses of Brain Metastases versus Primary Non-Small Cell Lung Cancer Reveal a Unique microRNA Signature

Surgical waiting times and all-cause mortality in patients with non-metastatic renal cell carcinoma

Rosenblad, Andreas; Sundqvist, Pernilla; Harmenberg, Ulrika; Hellström, Mikael et al.

Ingår i Scandinavian journal of urology, s. 383-390, 2022

• DOI för Surgical waiting times and all-cause mortality in patients with non-metastatic renal cell carcinoma
• Ladda ner fulltext (pdf) av Surgical waiting times and all-cause mortality in patients with non-metastatic renal cell carcinoma

Clinical T1a Renal Cell Carcinoma, Not Always a Harmless Disease—A National Register Study

Almdalal, Tarik; Sundqvist, Pernilla; Harmenberg, Ulrika; Hellström, Mikael et al.

Ingår i European Urology Open Science, s. 22-28, 2022

• DOI för Clinical T1a Renal Cell Carcinoma, Not Always a Harmless Disease—A National Register Study
• Ladda ner fulltext (pdf) av Clinical T1a Renal Cell Carcinoma, Not Always a Harmless Disease—A National Register Study

Ilixadencel, a Cell-based Immune Primer, plus Sunitinib Versus Sunitinib Alone in Metastatic Renal Cell Carcinoma: A Randomized Phase 2 Study

Lindskog, Magnus; Laurell, Anna; Kjellman, Anders; Melichar, Bohuslav et al.

Ingår i European Urology Open Science, s. 38-45, 2022

• DOI för Ilixadencel, a Cell-based Immune Primer, plus Sunitinib Versus Sunitinib Alone in Metastatic Renal Cell Carcinoma: A Randomized Phase 2 Study
• Ladda ner fulltext (pdf) av Ilixadencel, a Cell-based Immune Primer, plus Sunitinib Versus Sunitinib Alone in Metastatic Renal Cell Carcinoma: A Randomized Phase 2 Study

Acute healthcare utilization in end-of-life among Swedish brain tumor patients - a population based register study

Lindskog, Magnus; Schultz, Torbjorn; Strang, Peter

Ingår i BMC Palliative Care, 2022

• DOI för Acute healthcare utilization in end-of-life among Swedish brain tumor patients - a population based register study
• Ladda ner fulltext (pdf) av Acute healthcare utilization in end-of-life among Swedish brain tumor patients - a population based register study

Metastatic renal cell carcinoma to the brain: optimizing patient selection for gamma knife radiosurgery

Stenman, Maria; Benmakhlouf, H.; Wersäll, P.; Johnstone, P. et al.

Ingår i Acta Neurochirurgica, s. 333-342, 2021

• DOI för Metastatic renal cell carcinoma to the brain: optimizing patient selection for gamma knife radiosurgery

An immune gene expression signature distinguishes central nervous system metastases from primary tumours in non-small-cell lung cancer

Tsakonas, Georgios; Lewensohn, Rolf; Botling, Johan; Ortiz-Villalon, Cristian et al.

Ingår i European Journal of Cancer, s. 24-34, 2020

• DOI för An immune gene expression signature distinguishes central nervous system metastases from primary tumours in non-small-cell lung cancer
• Ladda ner fulltext (pdf) av An immune gene expression signature distinguishes central nervous system metastases from primary tumours in non-small-cell lung cancer

Metastatic papillary renal cell carcinoma in the era of targeted therapy: a retrospective study from three European academic centres

Stenman, Maria; Staehler, Michael; Szabados, Bernadett; Sandström, Per et al.

Ingår i Acta Oncologica, s. 306-312, 2019

• DOI för Metastatic papillary renal cell carcinoma in the era of targeted therapy: a retrospective study from three European academic centres
• Ladda ner fulltext (pdf) av Metastatic papillary renal cell carcinoma in the era of targeted therapy: a retrospective study from three European academic centres

Cancer patients hospitalised in the last week of life risk insufficient care quality - a population-based study from the Swedish Register of Palliative Care

Elmstedt, Sixten; Mogensen, Hanna; Hallmans, Dan-Erik; Tavelin, Björn et al.

Ingår i Acta Oncologica, s. 432-438, 2019

• DOI för Cancer patients hospitalised in the last week of life risk insufficient care quality - a population-based study from the Swedish Register of Palliative Care
• Ladda ner fulltext (pdf) av Cancer patients hospitalised in the last week of life risk insufficient care quality - a population-based study from the Swedish Register of Palliative Care

Real-world cost-effectiveness of targeted therapy in metastatic renal cell carcinoma in Sweden: a population-based retrospective analysis

Redig, Josefine; Dalen, Johan; Harmenberg, Ulrika; Lindskog, Magnus et al.

Ingår i Cancer Management and Research, s. 1289-1297, 2019

• DOI för Real-world cost-effectiveness of targeted therapy in metastatic renal cell carcinoma in Sweden: a population-based retrospective analysis
• Ladda ner fulltext (pdf) av Real-world cost-effectiveness of targeted therapy in metastatic renal cell carcinoma in Sweden: a population-based retrospective analysis

Disulfiram repurposing combined with nutritional copper supplement as add-on to chemotherapy in recurrent glioblastoma (DIRECT): Study protocol for a randomized controlled trial

Jakola, Asgeir Store; Werlenius, Katja; Mudaisi, Munila; Hylin, Sofia et al.

Ingår i F1000 Research, s. 1797, 2018

• DOI för Disulfiram repurposing combined with nutritional copper supplement as add-on to chemotherapy in recurrent glioblastoma (DIRECT): Study protocol for a randomized controlled trial
• Ladda ner fulltext (pdf) av Disulfiram repurposing combined with nutritional copper supplement as add-on to chemotherapy in recurrent glioblastoma (DIRECT): Study protocol for a randomized controlled trial

Overall survival after stereotactic radiotherapy or surgical metastasectomy in oligometastatic renal cell carcinoma patients treated at two Swedish centres 2005-2014

Stenman, Maria; Sinclair, G.; Paavola, P.; Wersall, P. et al.

Ingår i Radiotherapy and Oncology, s. 501-506, 2018

• DOI för Overall survival after stereotactic radiotherapy or surgical metastasectomy in oligometastatic renal cell carcinoma patients treated at two Swedish centres 2005-2014

Overall survival in Swedish patients with renal cell carcinoma treated in the period 2002 to 2012: Update of the RENCOMP study with subgroup analysis of the synchronous metastatic and elderly populations

Lindskog, Magnus; Wahlgren, Thomas; Sandin, Rickard; Kowalski, Jan et al.

Ingår i Urologic Oncology, 2017

• DOI för Overall survival in Swedish patients with renal cell carcinoma treated in the period 2002 to 2012: Update of the RENCOMP study with subgroup analysis of the synchronous metastatic and elderly populations

Heed or disregard a cancer patient's critical blogging?: An experimental study of two different framing strategies

Lynoe, Niels; NattochDag, Sara; Lindskog, Magnus; Juth, Niklas

Ingår i BMC Medical Ethics, 2016

• DOI för Heed or disregard a cancer patient's critical blogging?: An experimental study of two different framing strategies
• Ladda ner fulltext (pdf) av Heed or disregard a cancer patient's critical blogging?: An experimental study of two different framing strategies

Metastatic papillary renal cell carcinoma: A retrospective study from two large academic centers in Sweden

Stenman, Maria; Nearchou, Andreas Demetrios; Sandström, Per; Lindskog, Magnus et al.

Ingår i Journal of Clinical Oncology, 2016

Old age as risk indicator for poor end-of-life care quality - A population-based study of cancer deaths from the Swedish Register of Palliative Care

Lindskog, Magnus; Tavelin, Bjorn; Lundstrom, Staffan

Ingår i European Journal of Cancer, s. 1331-1339, 2015

• DOI för Old age as risk indicator for poor end-of-life care quality - A population-based study of cancer deaths from the Swedish Register of Palliative Care

Overall survival (OS) in Swedish RCC patients treated 2000-2012: Update of the RENCOMP study

Lindskog, Magnus; Wahlgren, Thomas; Sandin, Rickard; Kowalski, Jan et al.

Ingår i Journal of Clinical Oncology, 2015

Prognostic significance of serum albumin in patients with metastatic renal cell carcinoma

Stenman, Maria; Laurell, Anna; Lindskog, Magnus

Ingår i Medical Oncology, s. 841, 2014

• DOI för Prognostic significance of serum albumin in patients with metastatic renal cell carcinoma

Predictive role of plasma vascular endothelial growth factor for the effect of celecoxib in advanced non-small cell lung cancer treated with chemotherapy

Sörenson, S.; Fohlin, H.; Lindgren, A.; Lindskog, Magnus et al.

Ingår i European Journal of Cancer, s. 115-120, 2013

• DOI för Predictive role of plasma vascular endothelial growth factor for the effect of celecoxib in advanced non-small cell lung cancer treated with chemotherapy

Omega-3 from fish oil augments GVHD through the enhancement of chemotherapy conditioning regimen and selective FoxP3 depletion

Al Hashmi, S.; Sadeghi, B.; Hassan, Z.; Abedi-Valugerdi, M. et al.

Ingår i Bone Marrow Transplantation, s. 843-848, 2013

• DOI för Omega-3 from fish oil augments GVHD through the enhancement of chemotherapy conditioning regimen and selective FoxP3 depletion

Omega-3 fatty acid supplementation delays the progression of neuroblastoma in vivo

Gleissman, Helena; Segerström, Lova; Hamberg, Mats; Ponthan, Frida et al.

Ingår i International Journal of Cancer, s. 1703-1711, 2011

• DOI för Omega-3 fatty acid supplementation delays the progression of neuroblastoma in vivo

Fish oil delays lymphoma progression in the TLL mouse

Johansson, Ann-Sofie; Norén-Nyström, Ulrika; Larefalk, Åsa; Holmberg, Dan et al.

Ingår i Leukemia and Lymphoma, s. 2092-2097, 2010

• DOI för Fish oil delays lymphoma progression in the TLL mouse

Cytotoxic effects of cardiac glycosides in colon cancer cells, alone and in combination with standard chemotherapeutic drugs

Felth, Jenny; Rickardson, Linda; Rosén, Josefin; Wickström, Malin et al.

Ingår i Journal of natural products (Print), s. 1969-1974, 2009

• DOI för Cytotoxic effects of cardiac glycosides in colon cancer cells, alone and in combination with standard chemotherapeutic drugs

Lymphoblastic T-cell lymphoma in mice is unaffected by Celecoxib as single agent or in combination with cyclophosphamide

Johansson, Ann-Sofie; Pawelzik, Sven-Christian; Larefalk, Åsa; Jakobsson, Per-Johan et al.

Ingår i Leukemia and Lymphoma, s. 1198-1203, 2009

• DOI för Lymphoblastic T-cell lymphoma in mice is unaffected by Celecoxib as single agent or in combination with cyclophosphamide

The novel melphalan prodrug J1 inhibits neuroblastoma growth in vitro and in vivo

Wickström, Malin; Johnsen, John Inge; Ponthan, Frida; Segerström, Lova et al.

Ingår i Molecular Cancer Therapeutics, s. 2409-2417, 2007

• DOI för The novel melphalan prodrug J1 inhibits neuroblastoma growth in vitro and in vivo

Glycaemic control in end-of-life care: fundamental or futile?

Lindskog, Magnus; Karvestedt, Lars; Furst, Carl Johan

Ingår i Current Opinion in Supportive and Palliative Care, s. 378-382, 2014

• DOI för Glycaemic control in end-of-life care: fundamental or futile?

Albumin, corticosteroid use and Karnofsky performance status predict outcome of single-fraction gamma knife radiosurgery in clear cell renal cell carcinoma patients with brain metastases

Stenman, Maria; Benmakhlouf, Hamza; Wersäll, Peter; Hatiboglu, Mustafa Aziz et al.

Survival prediction in locally advanced non-small cell lung cancer using supervoxel-based longitudinal analysis of whole-body [¹⁸F]FDG PET/CT

Jönsson, Hanna; Holmstrand, Hanna; Öfverstedt, Johan; Hansen, Tomas et al.